Paul Hetrick, PharmD Published: Mar 27, 2025 Key takeaway: If Wegovy is too expensive, unavailable, or not the right fit, several strong alternatives exist including tirzepatide (Zepbound), oral semaglutide, and non-GLP-1 medications
Triple Receptor Pharmacology Retatrutide The only triple GIP/GLP-1/glucagon agonist in advanced clinical development, offering a unique mechanism that may provide metabolic benefits beyond dual agonism
By contrast, multi-ingredient formulas can make it harder to determine which ingredient is responsible for a particular outcome
And due to it has broad pharmaceutical know-how, along with a real international market footprint, Pfizer matters a lot in the healthcare space, especially where metabolic treatment is concerned
R., & Turner, N